H2-receptor antagonists
Tagamet
The FDA lists this product in 2 strengths and forms.
Composition
- Active ingredients
- CIMETIDINE HYDROCHLORIDE EQ 300MG BASE/2ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CIMETIDINE HYDROCHLORIDE EQ 300MG BASE/2ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
- CIMETIDINE HYDROCHLORIDE EQ 300MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SolutionNDA017924-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA017939.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.



